Eva Pike
Impact in
- Nephrology top 10%
- Dialysis and Renal Disease Management
- Rheumatology top 10%
- Folate and B Vitamins Research
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 4
-
- Schizophrenia research and treatment 3
- Co-authors
- Marianne Klemp (9 shared papers)Torbjørn Wisløff (5 shared papers)B Skuterud (5 shared papers)Annetine Staff (1 shared paper)Sigbjørn Smeland (1 shared paper)Tale Norbye Wien (1 shared paper)Peter Kierulf (4 shared papers)P. K. M. Lunde (3 shared papers)
- Journals
- BMJ Open (2 papers)Clinical Pharmacology & Therapeutics (2 papers)British Journal of Clinical Pharmacology (2 papers)Clinical Pharmacokinetics (2 papers)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- Norway
In The Last Decade
Eva Pike
17 papers receiving 356 citations
Peers
Comparison fields: 5 of 90
- Nephrology 53
- Rheumatology 103
- Emergency Medical Services 21
- Pharmacology 21
- Oncology 62
Countries citing papers authored by Eva Pike
This map shows the geographic impact of Eva Pike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Pike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Pike more than expected).
Fields of papers citing papers by Eva Pike
This network shows the impact of papers produced by Eva Pike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Pike. The network helps show where Eva Pike may publish in the future.
Co-authors
The 16 scholars most cited alongside Eva Pike, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 143 | |
| 2 | 2016 | 47 | |
| 3 | 1981 | 33 | |
| 4 | 1982 | 24 | |
| 5 | 1984 | 20 | |
| 6 | 1982 | 20 | |
| 7 | 1982 | 19 | |
| 8 | 2017 | 18 | |
| 9 | 1983 | 17 | |
| 10 | 2009 | 6 | |
| 11 | Health Technology Assessment of the Different Dialysis Modalities in Norway | 2013 | 5 |
| 12 | Efficacy and Safety of First-Generation and Second-Generation Anti-Psychotic Drugs for Schizophrenia in Adults: An Overview of Systematic Reviews | 2009 | 4 |
| 13 | Baroreflex activation therapy for drug-resistant hypertension. A single technology assessment | 2017 | 3 |
| 14 | A health technology assessment of the new drugs for inoperable or metastatic malignant melanoma patients | 2015 | 3 |
| 15 | Health Technology Assessment of Four Drugs for Patients with Metastatic Castration Resistant Prostate Cancer | 2016 | 2 |
| 16 | Effekt og sikkerhet av første- og annengenerasjons antipsykotika ved schizofreni hos voksne | 2009 | 1 |
| 17 | Effekt og sikkerhet for SSRI og andre nyere antidepressive legemidler ved depresjon hos voksne | 2007 | 1 |
| 18 | The Use of Naltrexone in Low Doses Beyond the Approved Indication [Internet] | 2015 | 1 |
About Eva Pike
Eva Pike is a scholar working on Economics and Econometrics, Psychiatry and Mental health, Molecular Biology, Pulmonary and Respiratory Medicine and Oncology, having authored 18 papers that have together received 367 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (4 papers), Schizophrenia research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Treatment of Major Depression (2 papers), Pharmacovigilance and Adverse Drug Reactions (1 paper), Mental Health and Psychiatry (1 paper) and Computational Drug Discovery Methods (1 paper). The work is most often cited by research in Nephrology (53 citations), Rheumatology (103 citations), Emergency Medical Services (21 citations), Pharmacology (21 citations) and Oncology (62 citations). Eva Pike has collaborated with scholars based in Norway. Frequent co-authors include Marianne Klemp, Torbjørn Wisløff, B Skuterud, Annetine Staff, Sigbjørn Smeland, Tale Norbye Wien, Peter Kierulf, P. K. M. Lunde, Vida Hamidi and Tove Ringerike. Their work appears in journals such as BMJ Open, Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology, Clinical Pharmacokinetics and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.